Back
Aligos Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
ALGS
Aligos Therapeutics
Last Price:
$5.82
Seasonality Move:
-16.73%
7 Day Trial
ALL ACCESS PASS
$
7
Aligos Therapeutics Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 53.6% based on the past 4 years of stock performance.
-
Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Aligos Therapeutics Stock Undervalued?The current Aligos Therapeutics [ALGS] share price is $5.95. The Score for ALGS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 53.6% based on the past 4 years of stock performance.
Aligos Therapeutics Stock Rating
Sell
45
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics overpriced?
-
Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Aligos Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
46.80
52-Week Low:
3.76
Prediction Charts
Market Cap:
36.4M
Price in USD:
5.95
Volume:
126.7K
Beta:
2.70
Technical Analysis
SMA50:
5.93
SMA100:
13.82
SMA200:
15.92
52-Wk Change:
-61.41%
Stock Predictions
-
Is Aligos Therapeutics stock public?Yes, Aligos Therapeutics is a publicly traded company.
-
What is the Aligos Therapeutics stock quote today?The Aligos Therapeutics stock price is 5.95 USD today.
-
How to buy Aligos Therapeutics stock online?You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-14 | 5.94 | 5.56 | 6.44 | 5.44 |
| May-15 | 5.48 | 5.80 | 5.91 | 5.23 |
| May-16 | 5.89 | 5.84 | 6.08 | 5.57 |
| May-19 | 5.67 | 5.89 | 5.97 | 5.51 |
| May-20 | 6.00 | 6.06 | 6.28 | 5.77 |
| May-21 | 5.88 | 5.63 | 6.08 | 5.45 |
| May-22 | 5.53 | 5.67 | 5.90 | 5.46 |
| May-23 | 5.52 | 5.50 | 5.81 | 5.33 |
| May-27 | 5.66 | 5.59 | 5.95 | 5.50 |
| May-28 | 5.53 | 5.79 | 5.88 | 5.47 |
| May-29 | 5.83 | 5.74 | 6.12 | 5.55 |
| May-30 | 5.58 | 5.29 | 5.58 | 5.12 |
| Jun-2 | 5.26 | 5.25 | 5.56 | 5.12 |
| Jun-3 | 5.28 | 5.95 | 5.95 | 5.27 |
Aligos Therapeutics Earnings
Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics Forecast Revenue Growth
Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.